An open-label study of the safety and efficacy of triple-combination therapy of melasma in african-american patients

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2003.10.478 ◽

2004 ◽

Vol 50 (3) ◽

pp. P138

Author(s):

Pearl E Grimes

Keyword(s):

African American ◽

Combination Therapy ◽

Triple Combination ◽

Triple Combination Therapy ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

An open-label study of the safety and efficacy of triple-combination therapy of melasma in African-American patients

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2003.11.028 ◽

2004 ◽

Vol 50 (3) ◽

pp. P176

Author(s):

Pearl Grimes

Keyword(s):

African American ◽

Combination Therapy ◽

Triple Combination ◽

Triple Combination Therapy ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

An open-label study of the use of adapalene cream and a triple-combination therapy for the treatment of mild-to-moderate acne and post-inflammatory hyperpigmentation

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2003.11.003 ◽

2004 ◽

Vol 50 (3) ◽

pp. P169 ◽

Author(s):

Valerie D. Callender

Keyword(s):

Combination Therapy ◽

Triple Combination ◽

Triple Combination Therapy ◽

Open Label Study ◽

Download Full-text

Correction to: Rakugi et al., A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension

Blood Pressure ◽

10.1080/08037051.2018.1428781 ◽

2018 ◽

Vol 27 (3) ◽

pp. 184-184

Keyword(s):

Essential Hypertension ◽

Combination Therapy ◽

Multicenter Study ◽

Phase Iii ◽

Triple Combination ◽

Triple Combination Therapy ◽

Safety And Efficacy

Download Full-text

A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension

Blood Pressure ◽

10.1080/08037051.2017.1412797 ◽

2017 ◽

Vol 27 (3) ◽

pp. 125-133 ◽

Author(s):

Hiromi Rakugi ◽

Kohei Shimizu ◽

Yuya Nishiyama ◽

Yuhei Sano ◽

Yuusuke Umeda

Keyword(s):

Essential Hypertension ◽

Combination Therapy ◽

Multicenter Study ◽

Phase Iii ◽

Triple Combination ◽

Triple Combination Therapy ◽

Safety And Efficacy

Download Full-text

Efficacy and tolerability of a switch to fixed-dose combination therapy with amlodipine besylate/benazepril hydrochloride after monotherapy with amlodipine besylate: Data from the African-American subpopulation of a practice-based, open-label study (the LOGIC study)*1

Current Therapeutic Research ◽

10.1016/s0011-393x(04)90028-8 ◽

2004 ◽

Vol 65 (2) ◽

pp. 138-148

Author(s):

M GATLIN

Keyword(s):

African American ◽

Combination Therapy ◽

Fixed Dose Combination ◽

Amlodipine Besylate ◽

Open Label Study ◽

Label Study ◽

Dose Combination

Download Full-text

A randomized, multi-center, open-label study to compare the safety and efficacy between afatinib monotherapy and combination therapy of afatinib and HAD-B1 for the locally advanced or metastatic NSCLC patients with EGFR mutations: Erratum

Medicine ◽

10.1097/md.0000000000028585 ◽

2022 ◽

Vol 101 (2) ◽

pp. e28585

Keyword(s):

Combination Therapy ◽

Locally Advanced ◽

Egfr Mutations ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Metastatic Nsclc ◽

Download Full-text

A randomized, multi-center, open-label study to compare the safety and efficacy between afatinib monotherapy and combination therapy of afatinib and HAD-B1 for the locally advanced or metastatic NSCLC patients with EGFR mutations

Medicine ◽

10.1097/md.0000000000023455 ◽

2020 ◽

Vol 99 (49) ◽

pp. e23455

Author(s):

Si-Yeon Song ◽

Su-Jeong Ha ◽

Ji-Hye Park ◽

So-Jung Park ◽

Seong Hoon Shin ◽

...

Keyword(s):

Combination Therapy ◽

Locally Advanced ◽

Egfr Mutations ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Metastatic Nsclc ◽

Download Full-text

Abstract OT-03-08: A Phase 2, open-label study to evaluate the safety and efficacy of the probody therapeutic (Pb-Tx) CX-2009 in metastatic HR-Positive/HER2-negative breast cancer (mHR+/HER2− BC) and of CX-2009 as monotherapy and in combination therapy with CX-072 in metastatic triple-negative breast cancer (TNBC)

10.1158/1538-7445.sabcs20-ot-03-08 ◽

2021 ◽

Author(s):

Kathy D. Miller ◽

Leisha A. Emens ◽

Sara Tolaney ◽

Sara A. Hurvitz ◽

Erika Hamilton ◽

...

Keyword(s):

Breast Cancer ◽

Combination Therapy ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Phase 2 ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

Safety and Efficacy of Aliskiren/Amlodipine/Hydrochlorothiazide Triple Combination in Patients With Moderate to Severe Hypertension: A 54-Week, Open-Label Study

Journal of Clinical Hypertension ◽

10.1111/j.1751-7176.2012.00706.x ◽

2012 ◽

Vol 14 (12) ◽

pp. 821-827 ◽

Author(s):

Alexander V. Murray ◽

Wolfgang Koenig ◽

Juan Garcia-Puig ◽

Samir Patel ◽

Alkaz Uddin PhD ◽

...

Keyword(s):

Severe Hypertension ◽

Triple Combination ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis

Case Medical Research ◽

10.31525/ct1-nct03977792 ◽

2019 ◽

Author(s):

Keyword(s):

Herpes Labialis ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Recurrent Herpes ◽

Download Full-text